Pictet Asset Management Holding SA Has $1.60 Million Position in Aehr Test Systems $AEHR

Pictet Asset Management Holding SA increased its stake in shares of Aehr Test Systems (NASDAQ:AEHR) by 187.7% during the 2nd quarter, Holdings Channel reports. The fund owned 16,654 shares of the semiconductor company’s stock after acquiring an additional 10,866 shares during the period. Pictet Asset Management Holding SA’s holdings in Aehr Test Systems were worth $1,600,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. Royal Bank of Canada increased its stake in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Aehr Test Systems by 8.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after purchasing an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Aehr Test Systems by 7.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after purchasing an additional 1,145 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Aehr Test Systems by 110.8% in the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after buying an additional 3,617 shares during the period. Finally, Rhumbline Advisers grew its stake in shares of Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after buying an additional 1,254 shares during the period. 69.69% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Insider Buying and Selling

In related news, Director Howard T. Slayen sold 5,700 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $133.03, for a total value of $758,271.00. Following the transaction, the director owned 140,667 shares of the company’s stock, valued at approximately $18,712,931.01. This trade represents a 3.89% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Rhea J. Posedel sold 5,973 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $140.00, for a total transaction of $836,220.00. Following the completion of the transaction, the director directly owned 381,989 shares in the company, valued at approximately $53,478,460. The trade was a 1.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 109,475 shares of company stock worth $13,827,160 over the last ninety days. Insiders own 6.80% of the company’s stock.

Analyst Ratings Changes

AEHR has been the subject of a number of research analyst reports. Freedom Capital raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Craig Hallum reiterated a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a report on Wednesday, July 15th. Jefferies Financial Group began coverage on Aehr Test Systems in a research note on Thursday. They issued a “buy” rating and a $175.00 price objective for the company. Weiss Ratings downgraded Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Finally, Zacks Research raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $136.67.

Aehr Test Systems Price Performance

Shares of NASDAQ AEHR opened at $134.06 on Friday. The stock has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10. The company has a 50-day moving average price of $92.83 and a 200-day moving average price of $71.45. Aehr Test Systems has a 1 year low of $16.38 and a 1 year high of $147.40.

Aehr Test Systems Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.